Advanced search
Publication Cover
Acta Oncologica Volume 46, 2007 - Issue 7
Journal homepage
1,258
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

Halfdan Sørbye Department of Oncology, Section of Oncology, Institute of Medicine, Haukeland University Hospital, Bergen, NorwayCorrespondence[email protected]
,
Åke Berglund Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, Uppsala, Sweden
,
Kjell Magne Tveit Department of Oncology, Ullevål University Hospital, Oslo, Norway
,
Dagfinn Øgreid Division of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
,
Eva Hoff Wanderås The Norwegian Radium Hospital, Oslo, Norway
,
Tore Wentzel-Larsen Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway
,
Olav Dahl Department of Oncology, Section of Oncology, Institute of Medicine, Haukeland University Hospital, Bergen, Norway
&
Bengt Glimelius Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, Uppsala, Sweden; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
 show all
Pages 982-988 | Received 15 Sep 2006, Published online: 08 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lieke G. E. M. Razenberg, Geert-Jan Creemers, Laurens V. Beerepoot, Allert H. Vos, Agnes J. van de Wouw, Huub A. A. M. Maas & Valery E. P. P. Lemmens. (2016) Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer. Acta Oncologica 55:12, pages 1443-1449.
Read now
Ramazan Yildiz, Suleyman Buyukberber, Aytug Uner, Deniz Yamac, Ugur Coskun, Ali Osman Kaya, Banu Ozturk, Emel Yaman & Mustafa Benekli. (2010) Bevacizumab Plus Irinotecan–Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens. Cancer Investigation 28:1, pages 33-37.
Read now

Articles from other publishers (11)

Xi Zhang, Qing-hong Chen, Ying Yang, Jing-xin Lin, Yan-chun Li, Tian-yu Zhong, Jie Chen, Si-qi Wu, Xiao-hu Chen, Rui-si Zhou, Jia-man Lin, Dong-qing Wang, Qiu-xing He, Yan-ting You, Xing-hong Zhou, Qiang Zuo, Yan-yan Liu, Jing-ru Cheng, Yi-fen Wu & Xiao-shan Zhao. (2022) Baseline serum uric acid level is associated with progression-free survival, disease control rate, and safety in postoperative patients with colorectal cancer treated by FOLFOX, FOLFIRI, or XELOX. Frontiers in Oncology 12.
Crossref
Laura M Legué, Nienke Bernards, Valery EPP Lemmens, Ignace HJT Hingh, Geert-Jan Creemers & Felice N Erning. (2019) Palliative chemotherapy for patients with synchronous metastases of small‐bowel adenocarcinoma: A reflection of daily practice. United European Gastroenterology Journal 7:10, pages 1380-1388.
Crossref
Joanna Todd. (2019) Moderate Psoriatic Arthritis and Perspectives from Phosphodiesterase-4 Inhibition. European Medical Journal, pages 31-39.
Crossref
Wen-Cong Ruan, Yue-Ping Che, Li Ding & Hai-Feng Li. (2019) Efficacy and Toxicity of Addition of Bevacizumab to Chemotherapy in Patients with Metastatic Colorectal Cancer. Combinatorial Chemistry & High Throughput Screening 21:10, pages 718-724.
Crossref
Lucila Soares da Silva Rocha & Rachel P. Riechelmann. (2018) Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges. Clinics 73, pages e542s.
Crossref
Yangbo Jiang, Hui Fan, Yongmei Jiang, Guirong Song, Feng Wang, Xiaofeng Li & Guoquan Li. (2017) Efficacy and safety of FOLFIRI and biotherapy versus FOLFIRI alone for metastatic colorectal cancer patients. Medicine 96:48, pages e8767.
Crossref
Ranhua Cao, Shuai Zhang, Dedong Ma & Likuan Hu. (2014) A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer. Medical Oncology 32:1.
Crossref
Barbara Vandendriessche, Filip Geurs & Ingeborg Hilderson. (2012) Raltitrexed + irinotecan as second-line chemotherapy in elderly patients with advanced colorectal cancer. Modern Chemotherapy 01:02, pages 5-10.
Crossref
Andrea Wang-Gillam, A. Craig Lockhart & Joel Picus. 2012. Cancer Metastasis. Cancer Metastasis 356 368 .
C. Qvortrup, M. Yilmaz, D. Ogreid, A. Berglund, L. Balteskard, J. Ploen, T. Fokstuen, H. Starkhammar, H. Sørbye, K. Tveit & P. Pfeiffer. (2008) Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil. Annals of Oncology 19:6, pages 1154-1159.
Crossref
H. Sorbye, C.-H. Köhne, D.J. Sargent & B. Glimelius. (2007) Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: A proposal for standardization of patient characteristic reporting and stratification. Annals of Oncology 18:10, pages 1666-1672.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.